US Top News and Analysis
CNBC is the world leader in business news and real-time financial market coverage. Find fast, actionable information.
394 items
-
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Global markets and businesses were thrown into disarray by U.S. President Donald Trump's tariff announcements on Thursday.
-
Nvidia positioned to weather Trump tariffs, chip demand 'off the charts,' says Altimeter's Gerstner
Altimeter Capital CEO Brad Gerstner told CNBC that he remains bullish on Nvidia despite President Trump's tariffs and their effect on the broader economy.
-
With Trump's reciprocal tariffs looming, here are our stocks with the most U.S. sales
Three of our portfolio holdings derive 100% of their sales domestically.
-
BlackRock CEO Larry Fink sees a $68 trillion market by 2040 in a key new area for the firm
The executive touted infrastructure investing as having "an opportunity so vast it's almost hard to grasp."
-
Why Wells Fargo’s asset cap could be a blessing in disguise as recession fears roil markets
Piper Sandler analysts upgraded the bank stock to a buy from a hold-equivalent rating.
-
Jim Cramer: How Amazon could help Trump in his tariff 'game of chicken' with China
"China, that's who an Amazon, a Walmart are fighting," Jim Cramer says.
-
Hard-hit Apple bounces back with the market, and an analyst is divided on our drug stocks
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
-
Defense stocks abruptly stem losses as Trump’s tariffs wreak havoc on global markets
European defense giants whipsawed on Monday, abruptly paring losses as investors continue to grapple with a broad stock market downturn.
-
The tariff-driven selling may not be over yet. Here's my strategy to navigate this tricky market
In his Sunday column for Investing Club subscribers, Jim Cramer explains what investors need to see before they start buying the tariff-driven dip.
-
Here are the 3 biggest things we're watching in the market in the week ahead
The S&P 500 slid further into a correction territory Friday. The Nasdaq sank into a bear market.
-
How Trump's tariffs rollout turned into stock market mayhem
What's happened is something worse than the worst-case scenario.
-
Jim Cramer identifies 4 stocks to consider buying as market plummets
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
-
Trump talking to Vietnam about a tariff deal is a good sign for the stock market
This sign that the president is listening to foreign leaders has us more constructive about the market and this manufactured selloff.
-
We're exiting our position in a health-care stock to raise some cash
We're cutting loose the smallest position in our portfolio.
-
Fintech stocks such as Affirm, PayPal plunge on concern Trump tariffs will hurt consumer spending
Fintech and credit card stocks were hit particularly hard in the market rout that followed President Donald Trump's tariff announcement.
-
Trump's tariffs slammed the market and our financial stocks. 1 of them is a buy
Shares of Goldman Sachs, BlackRock and Wells Fargo plunged Thursday amid the global market selloff.
-
This retailer just got upgraded as a winner from Trump's tariffs. It's one we love
TJX Companies is in a prime position to cash in on the tariff chaos, according to Citigroup.
-
We're jumping into this tariffs-driven market plunge and buying two stocks
One name has great pricing power, the other does most of its business in the U.S.
-
Jim Cramer says the selling in this portfolio stock is excessive — and why bond yields matter
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
-
Software stocks have had a bruising year. Why cybersecurity has been a relative outperformer
The long-term trends that should lift cybersecurity stocks remain intact despite a volatile market in 2025.
-
We're adding to a catalyst stock that the market has overlooked
A little bit of patience went a long way.
-
Warren Buffett's net worth is up so far in 2025—the rest of world's top 15 wealthiest people have all lost money
Some of the world's richest people lost tens of billions as President Trump's tariff announcement sparked market turmoil. One notable exception: Warren Buffett.
-
Jim Cramer's top 10 things to watch in the stock market Monday
U.S. stocks are set for another brutal open today after last week's tariff-driven carnage.
-
'I'm not going to panic' — Jim Cramer on Sunday's stock futures sell-off
Jim Cramer urged Investing Club members to keep a level head, despite Wall Street headed for an ugly open Monday.
-
El-Erian says U.S. recession risks are now 'uncomfortably high'
"If the U.S. slows down, the rest of the world will slow down more," the veteran economist warned.
-
Higher inflation, shaky markets: What to expect from Trump's tariff policies, according to economists
Trump's tariffs are likely to roil the economy, experts say. But they shouldn't derail your long-term plans.
-
Jim Cramer's top 10 things to watch in the stock market Thursday
Stock markets across the world are tumbling today after President Donald Trump's reciprocal tariffs were announced last night.
-
Amazon bid to buy TikTok. We like the stock with or without the popular app
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
-
We're adding to our position in a company that is wisely transforming itself
We identified the stock a few weeks ago as one to buy.
-
Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
The drug stock is higher over the past month while the S&P 500 has pulled back sharply.
-
Can the bulls ever get Trump back? What my time as an ‘Apprentice’ judge tells me
I think the president wants to throw off everyone except the bears, who are probably laughing at their good fortune.
-
Costco's not-so secret weapon: How Kirkland Signature is driving growth and profits
A weaker environment for consumer spending is playing right into one of Costco's biggest strengths.
-
Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
The Food and Drug Administration's top vaccine regulator Peter Marks has resigned, citing Sec. Robert F. Kennedy Jr.'s "misinformation and lies" around immunization.
-
Jim Cramer says a recession is likely but investors shouldn't panic sell
CNBC's Jim Cramer said on Monday that although he believes an economic recession is likely, investors should stay the course rather than panic and sell.
-
'Shop around' for best CD rates — but don't panic buy as stocks plunge, advisor says
Investors may get a better interest rate on certificates of deposit at banks by choosing a long-term CD and paying a withdrawal penalty.
-
Stocks are falling but are they getting any cheaper? It's hard to say right now
In moments of widespread uncertainty, a stock's price-to-earnings ratio may be difficult to trust.
-
Crocs' big bet on personalization paid off. Here's how it happened - and what investors are keeping an eye on now.
Crocs made cultural resurgence driven by personalization and celebrity partnerships. But its acquisition of HeyDude could present a threat to future growth.
-
Microsoft birthday celebration interrupted by employees protesting use of AI by Israeli military
Microsoft's 50th birthday celebration was interrupted by multiple protesters on Friday due the use of the company's AI by the Israeli military.
-
Here's why so few sports teams go public, even as valuations soar
Sports team values are soaring, but most stay private to avoid scrutiny, share dilution and the pressures of public ownership.
-
Commerce Secretary Lutnick says Trump's reciprocal tariffs will spur countries to examine their trade policies
In a CNBC interview, Lutnick said the moves will push countries to re-examine their policies and provide greater access for U.S. products.